Stephen Fortmann, MD, is an internist and epidemiologist who conducts research on heart disease prevention. He has conducted both population- and individual-level studies of cardiovascular risk factors and disease rates, smoking cessation, the influence of tobacco marketing on adolescent smoking, and exercise and diet change. Dr. Fortmann has more than 35 years of experience leading community and clinical research, beginning with the Stanford Five-City Project, a community cardiovascular disease prevention study funded by NHLBI from 1978 to 1998. He has published over 220 peer-reviewed journal articles.
Dr. Fortmann is currently leading a study to see if increased access to public transit benefits health or reduces health care costs. He is also jointly leading a study of cardiovascular disease among Asians and Pacific Islanders in Hawaii and California, and is a co-investigator on a study of diabetes disparities among these groups in Hawaii. Dr. Fortmann also serves as site PI on GRADE, a comparative effectiveness study seeking the best second-line drugs for diabetes. With Dr. Stephanie Fitzpatrick he is also studying the implementation of the diabetes prevention program in KPNW.
Dr. Fortmann came to CHR from Stanford University Medical School, where he was director of the Stanford Prevention Research Center and the Stanford Preventive Cardiology Clinic. He is the C. F. Rehnborg Professor in Disease Prevention (Emeritus) at Stanford and in 2005 he was elected to the National Academy of Medicine. Dr. Fortmann received his MD from the University of California, San Francisco, and postdoctoral training at Stanford University.
See all of Dr. Fortmann's publications
A new four-year study will evaluate diabetes prevention programs at Kaiser Permanente Northwest.
On the NIDDK’s Glycemia Reduction Approaches in Diabetes study, CHR shines as a top-performing recruitment site